News
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% at constant exchange rates and scope of consolidation.
Swipe to discover more
-
bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE-marking of VIDAS® VITAMIN B12 TOTAL, an automated quantitative test for use on the VIDAS® immunoassay instruments, for the measurement of total Vitamin B12 concentration in human serum or plasma. -
Global Response to the 2024 Mpox Outbreak: Need for Enhanced Diagnostics and Equitable Resource Distribution
Fast, effective diagnostics are crucial in the identification of individuals infected with monkeypox (MPXV); a potentially fatal virus previously known as monkeypox. The outbreak was declared a public health emergency of international concern by the World Health Organization (WHO) in August 2024, just two years after a similar occurrence in 2022. Many top health officials have called for a coordinated international response to curb the spread and save lives. Drawing on this experience, University of Alabama at Birmingham Professor and epidemiologist David O. Freedman, contributes insights into managing outbreaks in a post-pandemic world. -
Advancing the Global AMR Agenda: A Call for Multi-Sector Collaboration
On the sidelines of the 2024 United Nations High-Level Meeting on Antimicrobial Resistance (AMR), a multisectoral event titled “Advancing Together: Securing the Global AMR Agenda by Harnessing the Collective Strength of Multi-Sector Partnerships” took place on September 24 in New York. bioMérieux, in partnership with The Wellcome Trust, The American Society of Microbiology, Malawi, and the French Republic, organized the event to focus on fostering a collaborative ecosystem that establishes sustainable solutions across the entire AMR landscape. From diagnosis and treatment to surveillance and action plans, this initiative spanned human health, animals, and the environment.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19